Baidu
map

Cost-effectiveness analysis of prolonged-release fampridine to treat walking disability of multiple sclerosis in China

Zhao, XR; Yang, H; Wei, T; Zhao, J; Liu, J; Huang, Z; Zhu, L; Zhao, YN; Li, W

Zhao, YN (通讯作者),First Hosp China Med Univ, Shenyang 110001, Liaoning, Peoples R China.;Li, W (通讯作者),China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing 211198, Jiangsu, Peoples R China.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022; 11 (14): 1057

Abstract

Objectives: This study evaluates the cost-effectiveness of adding prolonged-release (PR)-fampridine to best supportive care (BSC) versus BSC alone in ......

Full Text Link


Baidu
map
Baidu
map
Baidu
map